🍄 Psychedelic Therapy Contraindication Screening Simulator

Psychiatric History Screening

Personal or family psychosis/mania history is a major contraindication.

• High: Psychosis risk factor (Placeholder metric.)
• SCID-5: Screening tool (Placeholder metric.)
• Absolute: Bipolar I flag (Placeholder metric.)
• Moderate: Family history weight (Placeholder metric.)

Psychiatric intake and risk flagging

Placeholder text describing psychiatric history screening steps.

Placeholder callout: personal psychosis history is an absolute contraindication.

Cardiovascular Risk Screening

Cardiac disease and uncontrolled hypertension raise dosing risk.

• 140/90: BP threshold (Placeholder metric.)
• Yes: ECG required (Placeholder metric.)
• Monitored: QTc concern (Placeholder metric.)
• If risk ≥7: Cardiology referral (Placeholder metric.)

Cardiac risk stratification

Placeholder text describing cardiovascular screening steps.

Placeholder callout: high cardiac risk defers eligibility pending consult.

Current Medication Review

Serotonergic and MAOI combinations pose interaction risk.

• Blunts effect: SSRI interaction (Placeholder metric.)
• Contraindicated: MAOI combo (Placeholder metric.)
• Seizure risk: Lithium risk (Placeholder metric.)
• 2-5 weeks: Washout period (Placeholder metric.)

Medication interaction audit

Placeholder text describing medication review steps.

Placeholder callout: MAOI use requires mandatory washout before dosing.

Family History Assessment

First-degree family history informs residual psychiatric risk.

• Weighted: First-degree relative (Placeholder metric.)
• Screened: Sudden cardiac death (Placeholder metric.)
• Reviewed: Genetic risk score (Placeholder metric.)
• Relative flag: Family psychosis (Placeholder metric.)

Family history intake

Placeholder text describing family history assessment steps.

Placeholder callout: strong family psychosis history adds caution flag.

Final Eligibility Determination

All screens combine into a single eligibility decision.

• ~65%: Eligible rate (Placeholder metric.)
• ~20%: Conditional rate (Placeholder metric.)
• ~15%: Ineligible rate (Placeholder metric.)
• Required: Review board (Placeholder metric.)

Composite eligibility decision

Placeholder text describing final eligibility determination.

Placeholder callout: any absolute contraindication overrides eligibility.